Core Insights - Therma Bright Inc. has appointed Michael Raimondo, a healthcare veteran with 30 years of experience, to its Board of Directors, transitioning from an advisory role [1][5] - Raimondo has a proven track record in sales negotiations, having secured over $500 million in sales contracts, and has held significant leadership positions at Abbott [2][4] - The company aims to leverage Raimondo's expertise to enhance market penetration and drive sales growth for its flagship medical device, Venowave, which addresses vascular issues [5] Company Overview - Therma Bright Inc. focuses on developing and partnering in advanced diagnostic and medical device technologies, providing innovative solutions for healthcare challenges [6] - The company trades on multiple exchanges, including TSXV, OTCQB, and FSE [6] Strategic Focus - Raimondo's primary focus will be on building a high-performance internal sales team and expanding market reach through strategic partnerships with medical device resellers [5] - The company highlights the significant market potential for Venowave, particularly for the 900,000 individuals affected by deep vein thrombosis annually in the U.S. [5]